Exploring the Efficacy of Treatments for Anxiety and Depression Among College Students

Sponsor
University of South Dakota (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06013930
Collaborator
Subtle Energy Funders Collective (Other)
51
1
3
16
3.2

Study Details

Study Description

Brief Summary

The goal of this randomized control group is to learn about effective treatments for college students experiencing anxiety and/or depression. The main questions this clinical trial aims to answer are: 1) Can alternative treatments decrease anxiety and/or depression among college students? 2) Can alternative treatments increase retention rates among college students experiencing anxiety and/or depression?

Participants will be randomly assigned to one of three intervention groups: external qigong, mindfulness meditation, or psychoeducation. Researchers will compare outcomes from each group to explore treatment differences.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: External Qigong
  • Behavioral: Mindfulness Meditation
  • Other: Psychoeducation
N/A

Detailed Description

Method/Design. This study will be a single-site, three-arm, randomized, controlled trial. College students (N=51) with elevated depression and/or anxiety will be randomized to either external qigong (EQ), mindfulness meditation (MM), or psychoeducation (PE). Each intervention will be applied for 30 minutes, once a week for three weeks in a community setting. The co-primary outcomes, depression and anxiety, and the secondary outcome, intention to persist in college, will be assessed by a blinded researcher at baseline, one-week post treatment, and one-month follow-up. Change in sense of connection during the treatment session, measured with a comprehensive battery of self-report indices, will be the primary therapeutic mechanism.

Aims and Objectives. The proposed project's central hypothesis is that EQ will increase students' mental health and intention to persist in college by balancing the flow of energy in their bodies. Aim 1. Examine EQ's acceptability in a sample of college students with depression and/or anxiety. Hypothesis: Student retention (i.e., attendance in both treatment sessions) and self-reported treatment acceptability will be better for EQ relative to PE. EQ and MM will demonstrate equivalent acceptability. Aim 2. Determine EQ's effect on anxiety, depression (co-primary outcomes), and intention to persist in college (secondary outcome) over time. Hypothesis: EQ will decrease depression and anxiety while increasing intention to persist in college relative to PE from baseline to one-month follow-up. The co-primary and secondary outcome scores will not differ between EQ and MM. Aim 3. Investigate EQ's immediate effect on students' sense of connection (therapeutic mechanism). Hypothesis: EQ will increase students' sense of connection relative to PE during the treatment sessions. EQ and MM will have equivalent effects on sense of connection.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
51 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomized to receive either: 1) External Qigong, 2) Mindfulness Meditation, or 3) Psychoeducation.Participants will be randomized to receive either: 1) External Qigong, 2) Mindfulness Meditation, or 3) Psychoeducation.
Masking:
Single (Outcomes Assessor)
Masking Description:
The PI will randomly assign participants to condition and coordinate treatment group scheduling; the assessor will be blinded to condition.
Primary Purpose:
Treatment
Official Title:
Exploring the Efficacy of Alternative Treatments for Depression and Anxiety Among College Students: A Randomized Control Trial
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: External Qigong

Participants will meet individually with the Qigong practitioner once a week for three weeks for 30-minute segments.

Behavioral: External Qigong
External Qigong will be facilitated by a seasoned Qigong practitioner. The Qigong practitioner will assist participants in learning how to use the healing powers of their bodies to decrease feelings of anxiety and/or depression

Experimental: Mindfulness Meditation

Participants will meet individually with the mindfulness practitioner once a week for three weeks for 30-minute segments.

Behavioral: Mindfulness Meditation
Mindfulness meditation will be facilitated by a seasoned mindfulness practitioner. Participants will be guided through a meditation designed to help increase a sense of interconnectedness among their college community. They will also learn how to deconstruct feelings of anxiety and/or depression into sensory, emotional, cognitive, and behavioral components.

Active Comparator: Psychoeducation

In the psychoeducation arm, participants will receive recordings online, once a week for three weeks which will be approximately 30 minutes in length.

Other: Psychoeducation
In the psychoeducation arm, participants will receive information related to managing anxiety and/or depression through a recorded presentation. Participants will learn about stress-management techniques to help reduce symptoms of anxiety and/or depression. They will also receive information on resources that could be helpful in treating anxiety and/or depression.

Outcome Measures

Primary Outcome Measures

  1. Anxiety [Change from baseline assessment, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    Symptoms of anxiety will be assessed through a trait anxiety assessment (State-Trait-Anxiety Inventory). The range of possible scores spans from a minimum score of 20 to a maximum score of 80 - the higher the score, the higher the symptoms of anxiety.

  2. Depression [Change from baseline assessment, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    Symptoms of depression will be assessed through a trait depression assessment (Beck Depression Inventory). Scores from the Beck Depression Inventory range from 0-63, with higher scores representing high depression levels.

Secondary Outcome Measures

  1. Intention to persist in college [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    Change in participants' intention to persist in college will be assessed through an individual item rated in a numeric rating scale. Scores range from 0 to 5 with higher scores reflecting greater intent to remain in college.

  2. Anxiety [Changes in participant's state anxiety will be captured within 5-minutes prior to each intervention and within 5 minutes after each intervention (mindfulness, external qigong, and psychoeducation).]

    Symptoms will be assessed through a state anxiety assessment. Scores range from 0-60 with higher scores indicating higher levels of anxiety.

  3. Depression [Changes in participant's state depression will be captured within 5-minutes prior to each intervention and within 5 minutes after each intervention (mindfulness, external qigong, and psychoeducation).]

    Symptoms will be assessed through a state depression assessment. Scores range from 0-20 with higher scores indicating higher levels of depression.

Other Outcome Measures

  1. Adverse Childhood Experiences questionnaire. [Baseline]

    Participants adverse childhood experiences will be assessed at baseline to explore how childhood adversities moderate outcomes.The ACEs questionnaire was adapted from the Felitti et al., (1998) wave two survey and current questions used by the CDC's telephone Behavioral Risk Factor Surveillance System survey collected in all 50 states. ACES range between 0-13 and the higher the score, the higher the number of ACES.

  2. Sensation Manikin [Changes in participant's state body sensations will be captured within 5-minutes prior to each intervention and within 5 minutes after each intervention (mindfulness, external qigong, and psychoeducation).]

    Change in the distribution of pleasant and unpleasant bodily sensations. Scores can range from 0-100 for pleasant (higher scores indicate higher pleasant feelings) and 0-100 for unpleasant feelings (higher scores indicate higher levels of unpleasant sensations).

  3. Trait Self-Transcendence [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    Change in trait self-transcendence from baseline through 3-month follow-up will be assessed with the Nondual Awareness Dimensional Assessment - Trait Version. Scores range from 0 to 52, with higher scores reflecting greater trait self-transcendence.

  4. Self-Transcendent State [Changes in participant's self-transcendence will be captured within 5-minutes prior to each intervention and within 5 minutes after each intervention (mindfulness, external qigong, and psychoeducation).]

    Change in self-transcendent state will be measured with the Nondual Awareness Dimensional Assessment - State Version. Scores range from 0 to 10, with higher scores reflecting greater self-transcendence.

  5. Perceived Discrimination [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    Changes in the perception of experiencing discrimination (Everyday Discrimination). Scores range from 0 -54 with higher scores indicating higher levels of discrimination.

  6. Connectedness to Nature Questionnaire [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    The effects on Connectedness to Nature as a moderator between treatment and outcomes. The scale consists of 16 items rated on a 5-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree) and is scored by creating a mean of the 16 items, with scores ranging from one to five, with higher scores indicating a stronger connectedness to nature than lower scores.

  7. Dispositional Mindfulness Scale [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    The Metacognitive Processes of Decentering scale (MPoD-t) will be used to assess the effects of dispositional mindfulness as a moderator between treatment and outcomes. Scores range from 0-80 with higher scores indicating higher dispositional mindfulness.

  8. Sense of Belonging in College [Baseline, post treatment (one week after the final treatment session), and follow-up (one month after the final treatment session).]

    The role of treatment type on the participant's sense of belonging in college. Scores range from 0-56 with higher scores indicating higher levels of belonging.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years or older.

  • Currently enrolled in a two or four-year college.

  • English speaking.

  • Willing to travel to the study location.

  • Access to a computer or smartphone with a Wifi connection.

  • Score of a three or higher on the Generalized Anxiety Disorder 2-item and/or score of a three or higher on the Patient Health Questionnaire-2.

Exclusion Criteria:
  • Not currently enrolled in college.

  • Not able to travel to the study location.

  • No access to a computer or smartphone with Wifi.

  • Score < 3 on the Generalized Anxiety Disorder-2 and < 3 on the Patient Health Questionnaire-2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of South Dakota Sioux Falls South Dakota United States 57107

Sponsors and Collaborators

  • University of South Dakota
  • Subtle Energy Funders Collective

Investigators

  • Principal Investigator: Natalie Lecy, PhD, Assistant Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of South Dakota
ClinicalTrials.gov Identifier:
NCT06013930
Other Study ID Numbers:
  • 22-247
First Posted:
Aug 28, 2023
Last Update Posted:
Aug 28, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 28, 2023